Request Free Sample
×
Predictive Genetic Testing and Consumer Wellness Genomics Market
ID: MRFR/LS/9360-HCR
120 Pages
October 2025
Predictive Genetic Testing & Consumer/Wellness Genomics Market Research Report Information by Test Type (Predictive Testing [Genetic Susceptibility Test, Predictive Diagnostic, and Population Screening], Consumer Genomics, and Wellness Genomics [Nutria Genetic, Skin & Metabolism Genetics, and Others], by Application (Breast & Ovarian Cancer, Cardiovascular Screening, Diabetic Screening & Monitoring, Colon Cancer, Parkinsonism/Alzheimer’s Disease, Urologic Screening/Prostate Cancer Screening, Orthopedic & Musculoskeletal, ...
Industry Developments
- In June 2021, Bio-Rad Laboratories, Inc. (US), Bioaster (France), and Genetic Analysis (Norway) partnered to provide genetic metabolic disorders on the microbiome. This augments the growth of the predictive genetic testing & consumer/wellness genomics
- In August 2020, Thermo Fischer Scientific introduced an Oncomine Myeloid Assay GX that enables users to identify biomarkers associated with myeloproliferative neoplasm by detecting over 600 fusion isotypes. This product has contributed to the market's expansion.
- In July 2020, 23andMe, Inc (California) collaborated with the giant GlaxoSmithKline (UK) to provide a genetic database of approximately ten million populations searching for cancer information. This added value and further fuels the growth of the predictive genetic testing & consumer/wellness genomics
- In February 2020, Bureau Gravimétrique International (China) signed an agreement with giant distributors in Brazil, Argentina, Peru, Ecuador, Colombia, and Mexico. The partnership paves the way for the company to extend its DNA sequencing and laboratory automation offerings in Latin America.
- In June 2019, Thermo Fisher Scientific Inc. (US) entered into a global research collaboration with predictive laboratories to concentrate on women's infertility via genetic factors. It is taking advantage of the market's apex.
Market Segmentation
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East
- Africa
- Latin America
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East
- Africa
- Latin America
By Test Type
- Predictive Testing
- Consumer Genomics
- Wellness Genomics
North America
- US
- Canada
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East
- Africa
- Latin America
By Setting Type
- Proteomic Testing
- Metabolic Testing
- Genomic Testing
Rest of the World
- Middle East
- Africa
- Latin America
By Application type
- Breast & Ovarian Cancer
- Cardiovascular Screening
- Colon Cancer
- Others
List of companies covered in this report:
- 23andMe, Inc. (California)
- Myriad Genetics, Inc. (US)
- Hoffmann-La Roche Ltd. (Switzerland)
- Abbott Laboratories (US)
- Genesis Genetics (US)
- Agilent Technologies (US)
- Thermo Fisher Scientific, Inc. (US)
- Bureau Gravimétrique International (China)
- Bio-Rad Laboratories Inc. (US)
- Illumina, Inc. (US)
- Counsyl, Inc. (California)
- ARUP Laboratories (US)
- Others
Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Region
- US
- Canada
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East
- Africa
- Latin America
Predictive Genetic Testing & Consumer/Wellness Genomics Recent Developments
- In June 2019, Thermo Fisher Scientific Inc. (US) entered into a global research collaboration with predictive laboratories to concentrate on women's infertility via genetic factors. It is taking advantage of the market's apex.
- In February 2020, Bureau Gravimétrique International (China) signed an agreement with giant distributors in Brazil, Argentina, Peru, Ecuador, Colombia, and Mexico. The partnership paves the way for the company to extend its DNA sequencing and laboratory automation offerings in Latin America.
- In July 2020, 23andMe, Inc (California) collaborated with the giant GlaxoSmithKline (UK) to provide a genetic database of approximately ten million populations searching for cancer information. This added value and further fuels the growth of the predictive genetic testing & consumer/wellness genomics
- In August 2020, Thermo Fischer Scientific introduced an Oncomine Myeloid Assay GX that enables users to identify biomarkers associated with myeloproliferative neoplasm by detecting over 600 fusion isotypes. This product has contributed to the market's expansion.
- In June 2021, Bio-Rad Laboratories, Inc. (US), Bioaster (France), and Genetic Analysis (Norway) partnered to provide genetic metabolic disorders on the microbiome. This augments the growth of the predictive genetic testing & consumer/wellness genomics
Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Test Type
- Wellness Genomics
- Nutria Genetic
- Skin & Metabolism Genetics
- Others
- Consumer Genomics
- Predictive Testing
- Genetic Susceptibility Test
- Predictive Diagnostic
- Population Screening
Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Application
- Breast & Ovarian Cancer
- Cardiovascular Screening
- Diabetic Screening & Monitoring
- Colon Cancer
- Parkinsonism/Alzheimer’s Disease
- Urologic Screening/Prostate Cancer Screening
- Orthopedic & Musculoskeletal
- Others
Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Setting Type
- Proteomic Testing
- Metabolic Testing
- Genomic Testing
Report Scope
| Report Attribute/Metric | Details |
| Market Size | USD 11.2 Billion |
| CAGR | 5.4% |
| Base Year | 2022 |
| Forecast Period | 2023-2032 |
| Historical Data | 2021 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Test Type, Application, and Setting Type |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World |
| Key Vendors | 23andMe, Inc. (California), Myriad Genetics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Genesis Genetics (US), Agilent Technologies (US), Thermo Fisher Scientific, Inc. (US), Bureau Gravimétrique International (China), Bio-Rad Laboratories Inc. (US), Illumina, Inc. (US), Counsyl, Inc. (California), ARUP Laboratories (US) |
| Key Market Opportunities | Rise of application in personalized medicine |
| Key Market Drivers | Usage of predictive genetic testing & consumer/wellness genomics in various applications |
Market Highlights
- Predictive Genetic Testing and Consumer Wellness Genomics Market Size
- Predictive Genetic Testing and Consumer Wellness Genomics Market Trends
- Predictive Genetic Testing and Consumer Wellness Genomics Market Analysis
- Predictive Genetic Testing and Consumer Wellness Genomics Market Share
- Predictive Genetic Testing and Consumer Wellness Genomics Companies
Author
Leave a Comment
FAQs
How Big is the Predictive Genetic Testing & Consumer/Wellness Genomics market?
The global predictive genetic testing & consumer/wellness genomics market size is expected to reach USD 5.4 billion by 2032 at 11.2% CAGR during the forecast period (2023 - 2032)
Who are the key competitors in the market of Predictive Genetic Testing & Consumer/Wellness Genomics?
23andMe, Inc. (California), Myriad Genetics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Genesis Genetics (US), Agilent Technologies (US), Thermo Fisher Scientific, Inc. (US), Bureau Gravimétrique International (China), Bio-Rad Laboratories Inc. (US), Illumina, Inc. (US), Counsyl, Inc. (California), ARUP Laboratories (US) are the key competitors in the market of Predictive Genetic Testing & Consumer/Wellness Genomics.
Which region is predicted to have the largest market share of Predictive Genetic Testing & Consumer/Wellness Genomics?
North America holds the largest share in the global market of Predictive Genetic Testing & Consumer/Wellness Genomics
What are the key factors driving the market of Predictive Genetic Testing & Consumer/Wellness Genomics?
Usage of predictive genetic testing & consumer/wellness genomics in various applications and Rising R&D initiatives for novel therapeutics are the key factors driving the market of Predictive Genetic Testing & Consumer/Wellness Genomics.
Which factors may act as market deterrents Predictive Genetic Testing & Consumer/Wellness Genomics?
High cost of genomic research instruments and Inadequate funding and lack of trained professionals may act as market deterrents Predictive Genetic Testing & Consumer/Wellness Genomics
Download Free Sample
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director